MDR MedAdvisor Ltd
- 0.450
- +0.010+2.27%
MedAdvisor Ltd News
Medadvisor Target Price Raised 31% to A$0.64/Share by Bell Potter>MDR.AU
Up 127% in 2024, Why This ASX Healthcare Stock Is Surging Again This Month
New Zealand Shares Flat on US Rate Cut Hopes; Ebos Boosts MedAdvisor Stake
Ebos Boosts MedAdvisor Stake; Says No Plan for Change of Control Proposal
Private Companies Own 34% of MedAdvisor Limited (ASX:MDR) Shares but Individual Investors Control 36% of the Company
MedAdvisor Price Target Raised 4.3% to A$0.49/Share by Bell Potter
MedAdvisor Solutions Forecasts Continued Growth for FY25 After Stellar Year
MedAdvisor to Deliver Maiden Profit in Fiscal 2024; Shares Jump 14%
MedAdvisor Ltd: MDR Record FY24 Performance with Positive EBITDA and NPAT
MedAdvisor Limited's (ASX:MDR) Path To Profitability
MedAdvisor Price Target Raised 6.8% to A$0.47/Share by Bell Potter
MedAdvisor Operating Revenue Rises 42% to AU$24.2 Million in March Quarter
PVM Adjusts Stake in MedAdvisor Ltd
Shareholders in MedAdvisor (ASX:MDR) Are in the Red If They Invested Five Years Ago
MedAdvisor Price Target Raised 4.8% to A$0.44/Share by Bell Potter
MedAdvisor Reports Higher Attributable Profit, Revenue in Fiscal H1
Institutions Profited After MedAdvisor Limited's (ASX:MDR) Market Cap Rose AU$41m Last Week but Private Companies Profited the Most
MedAdvisor Secures Scope of Practice Pilot Contract; Shares Decline 3%
MedAdvisor Initiated at Buy by Bell Potter
MedAdvisor Started at Buy by Canaccord Genuity >MDR.AU
Analysis
Price Target
No Data
